Drugs Health Pharma

Own bacteria may cause some infections in hospitals: Study

If you are in a hospital, then at times, you get bacterial infections from one source — yourself.

Read More
Drugs Pharma

Type 2 diabetes linked to an enzyme defect in obese people

In overweight or obese people, a defect in an enzyme, APT1, interferes with the ability to secrete insulin resulting in Type 2 diabetes,.

Read More
Drugs Pharma

Covid-19 viral genome sequence sharing with WHO falls 90%

The number of sequences to detect the presence of the Covid-19 viral genome, being shared with WHO, has dropped by more than 90%,.

Read More
Drugs Pharma

US drug regulator issues warning letter to Sun Pharma on CGMP

Indian drug major Sun Pharmaceutical’s western Indian facility of Halal has been issued a warning letter by the FDA for not conforming to Current Good.

Read More
Drugs Medical Pharma

Every 4.4 seconds, a child or youth died in 2021: WHO

A child or youth died every 4.4 seconds in 2021 and about five million children died before their fifth birthday, due to labor.

Read More
Drugs Pharma

AstraZeneca to acquire US-based CinCor for $1.8 billion

AstraZeneca, a British-Swedish global pharmaceutical and biotechnology company, will buy CinCor Pharma, Inc., for $1.8 billion, according to a statement.

Read More
Drugs Health Medical

A dietary supplement helps reverse signs of heart disease

Researchers have found that dietary supplement Tricaprin can help reverse heart disease due to plaque deposit

Read More
Drugs Pharma

Combined dish-and-chip technology to open ways to treat kidney disorder

US scientists have combined two technologies to show the effect of glucose in polycystic kidney disorder, a life-threatening genetic disorder, according to a.

Read More
Drugs Pharma

Moderna in $35 million licensing deal with CytomX

Moderna, a US-based biotechnology company, announced a $35 million licensing deal with cancer-focused drugmaker CytomX to develop messenger RNA therapies.

Read More
Drugs Pharma

FDA gives accelerated approval for Alzheimer’s drug

The FDA has granted accelerated approval for an intravenous drug to treat Alzheimer's Disease, according to a statement.

Read More